Identifying patterns in amyotrophic lateral sclerosis progression from sparse longitudinal data
© 2022. The Author(s), under exclusive licence to Springer Nature America, Inc..
The clinical presentation of amyotrophic lateral sclerosis (ALS), a fatal neurodegenerative disease, varies widely across patients, making it challenging to determine if potential therapeutics slow progression. We sought to determine whether there were common patterns of disease progression that could aid in the design and analysis of clinical trials. We developed an approach based on a mixture of Gaussian processes to identify clusters of patients sharing similar disease progression patterns, modeling their average trajectories and the variability in each cluster. We show that ALS progression is frequently nonlinear, with periods of stable disease preceded or followed by rapid decline. We also show that our approach can be extended to Alzheimer's and Parkinson's diseases. Our results advance the characterization of disease progression of ALS and provide a flexible modeling approach that can be applied to other progressive diseases.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:2 |
---|---|
Enthalten in: |
Nature computational science - 2(2022), 9 vom: 04. Sept., Seite 605-616 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Ramamoorthy, Divya [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 08.01.2024 Date Revised 10.02.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1038/s43588-022-00299-w |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM366680811 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM366680811 | ||
003 | DE-627 | ||
005 | 20240210233048.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240108s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1038/s43588-022-00299-w |2 doi | |
028 | 5 | 2 | |a pubmed24n1287.xml |
035 | |a (DE-627)NLM366680811 | ||
035 | |a (NLM)38177466 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Ramamoorthy, Divya |e verfasserin |4 aut | |
245 | 1 | 0 | |a Identifying patterns in amyotrophic lateral sclerosis progression from sparse longitudinal data |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 08.01.2024 | ||
500 | |a Date Revised 10.02.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2022. The Author(s), under exclusive licence to Springer Nature America, Inc. | ||
520 | |a The clinical presentation of amyotrophic lateral sclerosis (ALS), a fatal neurodegenerative disease, varies widely across patients, making it challenging to determine if potential therapeutics slow progression. We sought to determine whether there were common patterns of disease progression that could aid in the design and analysis of clinical trials. We developed an approach based on a mixture of Gaussian processes to identify clusters of patients sharing similar disease progression patterns, modeling their average trajectories and the variability in each cluster. We show that ALS progression is frequently nonlinear, with periods of stable disease preceded or followed by rapid decline. We also show that our approach can be extended to Alzheimer's and Parkinson's diseases. Our results advance the characterization of disease progression of ALS and provide a flexible modeling approach that can be applied to other progressive diseases | ||
650 | 4 | |a Journal Article | |
700 | 1 | |a Severson, Kristen |e verfasserin |4 aut | |
700 | 1 | |a Ghosh, Soumya |e verfasserin |4 aut | |
700 | 1 | |a Sachs, Karen |e verfasserin |4 aut | |
700 | 0 | |a Answer ALS |e verfasserin |4 aut | |
700 | 1 | |a Glass, Jonathan D |e verfasserin |4 aut | |
700 | 1 | |a Fournier, Christina N |e verfasserin |4 aut | |
700 | 0 | |a Pooled Resource Open-Access ALS Clinical Trials Consortium |e verfasserin |4 aut | |
700 | 0 | |a ALS/MND Natural History Consortium |e verfasserin |4 aut | |
700 | 1 | |a Herrington, Todd M |e verfasserin |4 aut | |
700 | 1 | |a Berry, James D |e verfasserin |4 aut | |
700 | 1 | |a Ng, Kenney |e verfasserin |4 aut | |
700 | 1 | |a Fraenkel, Ernest |e verfasserin |4 aut | |
700 | 1 | |a Baxi, Emily G |e investigator |4 oth | |
700 | 1 | |a Coyne, Alyssa N |e investigator |4 oth | |
700 | 1 | |a Mosmiller, Elizabeth |e investigator |4 oth | |
700 | 1 | |a Hayes, Lindsey |e investigator |4 oth | |
700 | 1 | |a Cerezo, Aianna |e investigator |4 oth | |
700 | 1 | |a Ahmad, Omar |e investigator |4 oth | |
700 | 1 | |a Roy, Promit |e investigator |4 oth | |
700 | 1 | |a Zeiler, Steven |e investigator |4 oth | |
700 | 1 | |a Krakauer, John W |e investigator |4 oth | |
700 | 1 | |a Li, Jonathan |e investigator |4 oth | |
700 | 1 | |a Donde, Aneesh |e investigator |4 oth | |
700 | 1 | |a Huynh, Nhan |e investigator |4 oth | |
700 | 1 | |a Adam, Miriam |e investigator |4 oth | |
700 | 1 | |a Wassie, Brook T |e investigator |4 oth | |
700 | 1 | |a Lenail, Alex |e investigator |4 oth | |
700 | 1 | |a Patel-Murray, Natasha Leanna |e investigator |4 oth | |
700 | 1 | |a Raghav, Yogindra |e investigator |4 oth | |
700 | 1 | |a Sachs, Karen |e investigator |4 oth | |
700 | 1 | |a Kozareva, Velina |e investigator |4 oth | |
700 | 1 | |a Tsitkov, Stanislav |e investigator |4 oth | |
700 | 1 | |a Ehrenberger, Tobias |e investigator |4 oth | |
700 | 1 | |a Kaye, Julia A |e investigator |4 oth | |
700 | 1 | |a Lima, Leandro |e investigator |4 oth | |
700 | 1 | |a Wyman, Stacia |e investigator |4 oth | |
700 | 1 | |a Vertudes, Edward |e investigator |4 oth | |
700 | 1 | |a Amirani, Naufa |e investigator |4 oth | |
700 | 1 | |a Raja, Krishna |e investigator |4 oth | |
700 | 1 | |a Thomas, Reuben |e investigator |4 oth | |
700 | 1 | |a Lim, Ryan G |e investigator |4 oth | |
700 | 1 | |a Miramontes, Ricardo |e investigator |4 oth | |
700 | 1 | |a Wu, Jie |e investigator |4 oth | |
700 | 1 | |a Vaibhav, Vineet |e investigator |4 oth | |
700 | 1 | |a Matlock, Andrea |e investigator |4 oth | |
700 | 1 | |a Venkatraman, Vidya |e investigator |4 oth | |
700 | 1 | |a Holewenski, Ronald |e investigator |4 oth | |
700 | 1 | |a Sundararaman, Niveda |e investigator |4 oth | |
700 | 1 | |a Pandey, Rakhi |e investigator |4 oth | |
700 | 1 | |a Manalo, Danica-Mae |e investigator |4 oth | |
700 | 1 | |a Frank, Aaron |e investigator |4 oth | |
700 | 1 | |a Ornelas, Loren |e investigator |4 oth | |
700 | 1 | |a Panther, Lindsey |e investigator |4 oth | |
700 | 1 | |a Gomez, Emilda |e investigator |4 oth | |
700 | 1 | |a Galvez, Erick |e investigator |4 oth | |
700 | 1 | |a Perez, Daniel |e investigator |4 oth | |
700 | 1 | |a Meepe, Imara |e investigator |4 oth | |
700 | 1 | |a Lei, Susan |e investigator |4 oth | |
700 | 1 | |a Pinedo, Louis |e investigator |4 oth | |
700 | 1 | |a Liu, Chunyan |e investigator |4 oth | |
700 | 1 | |a Moran, Ruby |e investigator |4 oth | |
700 | 1 | |a Sareen, Dhruv |e investigator |4 oth | |
700 | 1 | |a Landin, Barry |e investigator |4 oth | |
700 | 1 | |a Agurto, Carla |e investigator |4 oth | |
700 | 1 | |a Cecchi, Guillermo |e investigator |4 oth | |
700 | 1 | |a Norel, Raquel |e investigator |4 oth | |
700 | 1 | |a Thrower, Sara |e investigator |4 oth | |
700 | 1 | |a Luppino, Sarah |e investigator |4 oth | |
700 | 1 | |a Farrar, Alanna |e investigator |4 oth | |
700 | 1 | |a Pothier, Lindsay |e investigator |4 oth | |
700 | 1 | |a Yu, Hong |e investigator |4 oth | |
700 | 1 | |a Sinani, Ervin |e investigator |4 oth | |
700 | 1 | |a Vigneswaran, Prasha |e investigator |4 oth | |
700 | 1 | |a Sherman, Alexander V |e investigator |4 oth | |
700 | 1 | |a Farr, S Michelle |e investigator |4 oth | |
700 | 1 | |a Mandefro, Berhan |e investigator |4 oth | |
700 | 1 | |a Trost, Hannah |e investigator |4 oth | |
700 | 1 | |a Banuelos, Maria G |e investigator |4 oth | |
700 | 1 | |a Garcia, Veronica |e investigator |4 oth | |
700 | 1 | |a Workman, Michael |e investigator |4 oth | |
700 | 1 | |a Ho, Richie |e investigator |4 oth | |
700 | 1 | |a Baloh, Robert |e investigator |4 oth | |
700 | 1 | |a Roggenbuck, Jennifer |e investigator |4 oth | |
700 | 1 | |a Harms, Matthew B |e investigator |4 oth | |
700 | 1 | |a Prina, Carolyn |e investigator |4 oth | |
700 | 1 | |a Heintzman, Sarah |e investigator |4 oth | |
700 | 1 | |a Kolb, Stephen |e investigator |4 oth | |
700 | 1 | |a Stocksdale, Jennifer |e investigator |4 oth | |
700 | 1 | |a Wang, Keona |e investigator |4 oth | |
700 | 1 | |a Morgan, Todd |e investigator |4 oth | |
700 | 1 | |a Heitzman, Daragh |e investigator |4 oth | |
700 | 1 | |a Jamil, Arish |e investigator |4 oth | |
700 | 1 | |a Jockel-Balsarotti, Jennifer |e investigator |4 oth | |
700 | 1 | |a Karanja, Elizabeth |e investigator |4 oth | |
700 | 1 | |a Markway, Jesse |e investigator |4 oth | |
700 | 1 | |a McCallum, Molly |e investigator |4 oth | |
700 | 1 | |a Miller, Tim |e investigator |4 oth | |
700 | 1 | |a Joslin, Ben |e investigator |4 oth | |
700 | 1 | |a Alibazoglu, Deniz |e investigator |4 oth | |
700 | 1 | |a Ajroud-Driss, Senda |e investigator |4 oth | |
700 | 1 | |a Beavers, Jay C |e investigator |4 oth | |
700 | 1 | |a Bellard, Mary |e investigator |4 oth | |
700 | 1 | |a Bruce, Elizabeth |e investigator |4 oth | |
700 | 1 | |a Maragakis, Nicholas |e investigator |4 oth | |
700 | 1 | |a Cudkowicz, Merit E |e investigator |4 oth | |
700 | 1 | |a Berry, James |e investigator |4 oth | |
700 | 1 | |a Thompson, Terri |e investigator |4 oth | |
700 | 1 | |a Finkbeiner, Steven |e investigator |4 oth | |
700 | 1 | |a Thompson, Leslie M |e investigator |4 oth | |
700 | 1 | |a Van Eyk, Jennifer E |e investigator |4 oth | |
700 | 1 | |a Svendsen, Clive N |e investigator |4 oth | |
700 | 1 | |a Rothstein, Jeffrey D |e investigator |4 oth | |
773 | 0 | 8 | |i Enthalten in |t Nature computational science |d 2021 |g 2(2022), 9 vom: 04. Sept., Seite 605-616 |w (DE-627)NLM323523668 |x 2662-8457 |7 nnns |
773 | 1 | 8 | |g volume:2 |g year:2022 |g number:9 |g day:04 |g month:09 |g pages:605-616 |
856 | 4 | 0 | |u http://dx.doi.org/10.1038/s43588-022-00299-w |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 2 |j 2022 |e 9 |b 04 |c 09 |h 605-616 |